Editorial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 7, 2015; 21(33): 9688-9692
Published online Sep 7, 2015. doi: 10.3748/wjg.v21.i33.9688
Table 1 Cardiovascular risk in inflammatory bowel disease-the liaisons
StudyResults
MEDLINE, Cochrane Library, EMBASE meta-analysis; 33 studies enrolling 207814 IBD patients and 5774898 controls[5]Increased risk of venous thromboembolism
Increased risk of both ischemic heart disease and mesenteric ischemia
No increased risk of arterial thromboembolism
No increased cardiovascular mortality
Cohort study, 1708 patients (648 Crohn’s disease, 1060 ulcerative colitis), 35 yr follow-up[6]A cumulative risk of venous thromboembolism after 15 yr after the diagnosis of 1.5% similar for both CD and UC
Systematic review and meta-analysisModest increase in the risk of CVA, especially among women and in young patients (< 40-50 yr old)
9 studies 2424 CVA events in 5 studies and 6478 IHD events 6 studies[8]19% increase in the risk of IHD, primarily in women also
No increased risk of peripheral arterial thromboembolic events
Cohort study, 20795 new onset IBD patients matched with 199978 controls[9]Overall increased risk of MI, stroke, and cardiovascular death Increased risk during flares
Nation wide cohort study, 5436647 subjects without IBD or HF; follow up 11.8 yr 23681 IBD patients developed IBD follow up 6.4 yr37% increased risk of hospitalization for HF in IBD Increased risk during flares
86790 Danish patients with first-time MI[11]Increased risk of recurrent MI and for all-cause mortality especially during flares
Historical cohort study 2004-2010[12] Interventional catheterization databaseIBD patients had CAD at a younger age as compared with non-IBD patients
131 IBD patients and 524 matched controlsIBD patients less likely to be active smokers and had a lower body mass index. No difference in post-PCI outcome in patients with IBD vs non-IBD controls with CAD